About Sensus Healthcare, Inc.
https://www.sensushealthcare.comSensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices.
CEO
Joseph C. Sardano
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 19
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:728.92K
Value:$3.63M
PACIFIC RIDGE CAPITAL PARTNERS, LLC
Shares:573.39K
Value:$2.86M
DIMENSIONAL FUND ADVISORS LP
Shares:569.31K
Value:$2.84M
Summary
Showing Top 3 of 49
About Sensus Healthcare, Inc.
https://www.sensushealthcare.comSensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $6.88M ▼ | $5.28M ▲ | $-943K ▲ | -13.7% ▲ | $-0.06 ▲ | $622K ▲ |
| Q2-2025 | $7.32M ▼ | $4.85M ▼ | $-1.04M ▲ | -14.18% ▲ | $-0.06 ▲ | $-1.78M ▲ |
| Q1-2025 | $8.34M ▼ | $7M ▲ | $-2.57M ▼ | -30.82% ▼ | $-0.16 ▼ | $-2.5M ▼ |
| Q4-2024 | $13.07M ▲ | $5.38M ▲ | $1.55M ▲ | 11.83% ▼ | $0.09 ▲ | $1.86M ▲ |
| Q3-2024 | $8.84M | $3.75M | $1.22M | 13.75% | $0.07 | $1.6M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $24.45M ▲ | $58.3M ▼ | $7.1M ▲ | $51.19M ▼ |
| Q2-2025 | $22.16M ▲ | $58.85M ▼ | $6.79M ▼ | $52.06M ▼ |
| Q1-2025 | $19.07M ▼ | $60.21M ▼ | $7.18M ▲ | $53.03M ▼ |
| Q4-2024 | $22.06M ▼ | $62.16M ▲ | $6.34M ▲ | $55.83M ▲ |
| Q3-2024 | $22.56M | $59.86M | $5.73M | $54.13M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 ▲ | $0 ▼ | $0 ▲ | $0 | $2.29M ▼ | $0 ▼ |
| Q2-2025 | $-1.04M ▲ | $3.12M ▲ | $-27K ▼ | $0 ▲ | $3.09M ▲ | $3.09M ▲ |
| Q1-2025 | $-2.57M ▼ | $-2.68M ▼ | $-7K ▼ | $-300K ▼ | $-2.98M ▼ | $-2.68M ▼ |
| Q4-2024 | $1.55M ▲ | $-827K ▼ | $297K ▲ | $28K ▲ | $-502K ▼ | $-530K ▼ |
| Q3-2024 | $1.22M | $3.95M | $-337K | $-30K | $3.59M | $3.62M |
Revenue by Products
| Product | Q4-2024 | Q3-2025 | Q2-2025 | Q1-2025 |
|---|---|---|---|---|
 Product | $10.00M ▲ | $0 ▼ | $10.00M ▲ | $10.00M ▲ |
 Product Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Service | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Service Revenue | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 CHINA | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 Other | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED STATES | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ | $10.00M ▲ |
 ISRAEL | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Joseph C. Sardano
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 19
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Grade Summary
Showing Top 3 of 3
Price Target
Institutional Ownership
VANGUARD GROUP INC
Shares:728.92K
Value:$3.63M
PACIFIC RIDGE CAPITAL PARTNERS, LLC
Shares:573.39K
Value:$2.86M
DIMENSIONAL FUND ADVISORS LP
Shares:569.31K
Value:$2.84M
Summary
Showing Top 3 of 49